Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interplay of FGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP)

NCT03489993 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT03489993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03489993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interplay of FGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP)
Lead sponsor
Wake Forest University Health Sciences
Phase
Observational
Overall status
Completed
Start date
December 6, 2018
Completion date
December 23, 2020
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypophosphatemia, left ventricular hypertrophy, renin-angiotensin system, x-linked hypophosphatemia